BioMarin Pharmaceutical(DE:BM8)
€52.44+0.38 (+0.73%)
DE:BM8
BioMarin Pharmaceutical earnings date
€52.44
At close:+0.38 (+0.73%)
BioMarin Pharmaceutical (BM8) Q4 2025 Earnings Report
1 Followers
DE:BM8 Q4 2025 EPS Results
- Actual EPS
- -EUR 0.22
- Consensus EPS
- EUR 0.15
- Beat/Miss
- Missed by -EUR 0.37
- One Year Ago EPS
- EUR 0.58
DE:BM8 Q4 2025 Revenue Results
- Actual Revenue
- EUR 815.88M
- Expected Revenue
- EUR 760.01M
- Beat/Miss
- Beat by +EUR 55.87M
- YoY Revenue Growth
- +21.24%
Earnings Announcement Details
- Quarter
- Q4 2025
- Date
- 02/23/2026
- Time
- After Close
- Conference Call
- Monday, February 23, 2026
DE:BM8 Upcoming Earnings
BioMarin Pharmaceutical's next earnings date is estimated for February 24, 2027, based on past reporting schedules.
Q4 2025 Earnings Call Audio
DE:BM8 Q4 2025 Earnings Call
0:00 / 0:00
Q4 2025 Earnings Slide Deck
Q4 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:BM8 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 24, 2027 | 2026 (Q4) | 0.76- | -0.22 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -0.040.21 | -0.15 | 243.75% (+0.36) | |
| Aug 06, 2026 | 2026 (Q2) | 0.861.09 | 1.12 | -2.44% (-0.03) | |
| May 04, 2026 | 2026 (Q1) | 0.630.69 | 0.87 | -20.00% (-0.17) | |
| Feb 23, 2026 | 2025 (Q4) | 0.15-0.22 | 0.58 | -137.50% (-0.80) | |
| Oct 27, 2025 | 2025 (Q3) | -0.26-0.15 | 0.5 | -129.09% (-0.65) | |
| Aug 04, 2025 | 2025 (Q2) | 0.781.12 | 0.5 | 123.64% (+0.62) | |
| May 01, 2025 | 2025 (Q1) | 0.650.87 | 0.42 | 106.52% (+0.45) | |
| Feb 19, 2025 | 2024 (Q4) | 0.490.58 | 0.1 | 481.82% (+0.48) | |
| Oct 29, 2024 | 2024 (Q3) | 0.480.50 | 0.19 | 161.90% (+0.31) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


